National Viral Hepatitis Education, Awareness, and Capacity Building for Communities and Providers: Frequently Asked Questions [ARCHIVED]
CDC-RFA-PS21-2105
The content on this webpage is available for historical purposes. CDC is no longer reviewing or updating this content.
Key Dates
When are applications due?
Applications are due Friday, May 14, 2021, 11:59 p.m. U.S. Eastern Time, at www.grants.govexternal icon.
Is there an opportunity to learn more about PS21-2105 from CDC program officers?
Yes, there was an informational webinar pdf icon[PDF – 336 KB] offered on March 23, 2021, 1:00 p.m. U.S. Eastern Time via Zoom.
Are letters of intent to apply required?
Applicants are encouraged but not required to send a letter of intent to apply by April 7, 2021. Details are included in the NOFO.
What is the anticipated start date of the project?
Successful applicants can anticipate a project start date of September 30, 2021.
Submission Process
How does an organization apply to PS21-2105?
To access the application package for PS21-2105: National Viral Hepatitis Education, Awareness, and Capacity Building for Communities and Providers
- Go to: www.grants.govexternal icon
- Select: “Applicants” from the top menu
- Select: “Apply for Grants”
- Select: “Search for Opportunity Package”
- In the “Funding Opportunity Number” box, type: CDC-RFA-PS21-2105, click “search”
This website will be updated regularly with new information.
When are applications due?
Applications are due Friday, May 14, 2021, 11:59 p.m. U.S. Eastern Time, at www.grants.govexternal icon.
Are letters of intent to apply required?
Applicants are encouraged but not required to submit a letter of intent to apply by April 7, 2021. Additional details are included in the NOFO.
Are letters of support required? Is there a limit to how many letters of support may be submitted?
As noted in the section titled “Organizational Capacity of Recipients to Implement the Approach,” letters of support are required for documenting organizational capacity, and a maximum of five can be submitted.
Are there page limits for letters of support? Are these considered to be part of the Project Narrative?
No, there are no page limits for submitted letters of support, and letters of support will not be considered as part of the Project Narrative page limit.
Can video content be submitted as part of the application?
Video content may be submitted as part of the application. To do so, upload it to YouTube as “Unlisted” and then provide the link to the video content within the application.
Eligibility
What organizations are eligible to apply for PS21-2105?
This NOFO provides full and open competition; please refer to the section titled NOFO Eligibility Information.
Are foreign entities allowed to apply?
The scope of PS21-2105 is to build national U.S. capacity for community viral hepatitis awareness and testing and to train U.S. health care providers on hepatitis B and hepatitis C. Any applicant meeting eligibility criteria and able to fulfill this scope may apply.
Hep B United and University of Washington were funded before. Do they have unique advantage?
PS21-2105 offers full and open competition. All applications will be reviewed and scored by an objective review panel utilizing the evaluation criteria as described in the NOFO.
Award Information
What is the period of performance for PS21-2105?
The period of performance is five (5) years.
How many awards will be made?
It is anticipated that there will be two (2) awards made under Part A and one (1) award under Part B.
What is the total funding over the period of performance?
It is anticipated that $2,750,000 will be available over the five-year period of performance.
What is the expected yearly award?
It is anticipated that the yearly award will be $275,000 for Part A and $275,000 for Part B. These amounts are subject to availability of funds.
If CDC were to receive additional funding, is there a mechanism for additional funds to go toward this opportunity?
As noted in the NOFO, the number of awards is subject to funding availability. If additional viral hepatitis funding becomes available to CDC, CDC would consider awarding additional funds under this mechanism.
Program Guidance and Implementation
Does the Data Management Plan (DMP) apply to Part A applicants?
No, in Section 2. CDC Project Description under b. i. CDC Evaluation and Performance Measurement Strategy, language is included to note that this program does not involve the generation or collection of public health data and therefore a DMP is not required. This applies to both Part A and Part B.
What is your definition of a coalition that can apply for funding?
For this NOFO, a coalition is broadly defined as diverse public and private organizations with established relationships to priority populations organizations supported by a NOFO recipient to increase education and awareness of viral hepatitis among the community or communities served by the coalition organizations. The NOFO recipient will be required to lead, maintain, and grow the coalition and provide culturally responsive training, capacity building, and technical assistance activities to the coalition members.
For Part A, is there a preference for a national coalition or state/regional coalition?
For this NOFO, coalition membership should be defined by the epidemiology of the hepatitides among the priority population(s) identified for the coalition. It can be national, state, or regional depending on the planned scope of activities to achieve the greatest impact.
For Part B, the NOFO indicates that an applicant should have a pre-existing web-based viral hepatitis program that if funded will be updated to meet CDC guidelines. Is that correct?
It is expected that Part B applicants will have an existing web-based training platform for health care providers to which training curricula for hepatitis B and hepatitis C would be included. See Background and Overview for more information on the possible training content.